ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS 250 MG
ATOVAQUONE : 250 MG PROGUANIL HYDROCHLORIDE : 100 MG · DIN 02466783 · GLENMARK PHARMACEUTICALS CANADA INC.
Health Canada status: MARKETED
What is ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS?
ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS 250 MG contains ATOVAQUONE : 250 MG PROGUANIL HYDROCHLORIDE : 100 MG. It is listed in the Health Canada Drug Product Database under DIN 02466783, held by GLENMARK PHARMACEUTICALS CANADA INC., supplied as TABLET for ORAL administration. Health Canada currently lists it as marketed, status dated 30-Oct-2017. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 02466783 |
|---|---|
| Brand name | ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS |
| Generic / active ingredient | ATOVAQUONE : 250 MG PROGUANIL HYDROCHLORIDE : 100 MG |
| Manufacturer | GLENMARK PHARMACEUTICALS CANADA INC. |
| Strength | 250 MG |
| Dosage form | TABLET |
| Route of administration | ORAL |
| Schedule | Prescription |
| ATC code | P01BB51 PROGUANIL AND ATOVAQUONE |
| AHFS class | 84:80.00 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 30-Oct-2017 |
| Original market date | 2018-03-10 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code P01BB51 PROGUANIL AND ATOVAQUONE. 6 of 6 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| ATOVAQUONE PROGUANIL | 100 MG | TABLET | SANIS HEALTH INC | MARKETED | DIN 02421429 |
| MALARONE | 100 MG | TABLET | GLAXOSMITHKLINE INC | MARKETED | DIN 02238151 |
| MALARONE PEDIATRIC | 62.5 MG | TABLET | GLAXOSMITHKLINE INC | MARKETED | DIN 02264935 |
| MYLAN-ATOVAQUONE/PROGUANIL | 100 MG | TABLET | MYLAN PHARMACEUTICALS ULC | MARKETED | DIN 02402165 |
| TEVA-ATOVAQUONE PROGUANIL | 100 MG | TABLET | TEVA CANADA LIMITED | MARKETED | DIN 02380927 |
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Request a quote for ATOVAQUONE AND PROGUANIL HYDROCHLORIDE TABLETS
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.